Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mehran Karimi

Showing results (281-290 of 315) with videos related to

Pageof 32
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases|November 29, 2023
A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating AgentsSalvatore Di Maio, Pierluigi Marzuillo, Shahina Daar, et al.
Journal of Pharmacopuncture|August 29, 2018
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patientsHassan Abolghasemi, Yunes Panahi, Minoo Ahmadinejad, et al.
Pediatric Endocrinology Reviews : PER|March 1, 2014
Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatmentVincenzo De Sanctis, Ashraf T Soliman, Heba Elsedfy, et al.
International Journal of Hematology-Oncology and Stem Cell Research|December 9, 2016
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in IranMeysam Seyedifar, Farid Abedin Dorkoosh, Amir Ali Hamidieh, et al.
Hemoglobin|June 14, 2019
A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic AnemiaThomas R L Klei, Sima Kheradmand Kia, Martijn Veldthuis, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical StandpointVincenzo De Sanctis, Christos Kattamis, Duran Canatan, et al.
Haematologica|January 29, 2008
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remissionFlora Peyvandi, Silvia Lavoretano, Roberta Palla, et al.
Thrombosis and Haemostasis|December 15, 2012
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluationGuglielmo Mariani, Mariasanta Napolitano, Alberto Dolce, et al.
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A NetworkVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2019
Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patientsToshko Lissitchkov, Bella Madan, Claudia Djambas Khayat, et al.
Pageof 32

Showing results (281-290 of 315) with videos related to

Sort By:
Pageof 32
Mediterranean Journal of Hematology and Infectious Diseases|November 29, 2023
A Multicenter ICET-A Study on Age at Menarche and Menstrual Cycles in Patients with Transfusion-Dependent Thalassemia (TDT) who Started Early Chelation Therapy with Different Chelating AgentsSalvatore Di Maio, Pierluigi Marzuillo, Shahina Daar, et al.
Journal of Pharmacopuncture|August 29, 2018
Comparative evaluation of the safety and efficacy of recombinant FVIII in severe hemophilia A patientsHassan Abolghasemi, Yunes Panahi, Minoo Ahmadinejad, et al.
Pediatric Endocrinology Reviews : PER|March 1, 2014
Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatmentVincenzo De Sanctis, Ashraf T Soliman, Heba Elsedfy, et al.
International Journal of Hematology-Oncology and Stem Cell Research|December 9, 2016
Health-Related Quality of Life and Health Utility Values in Beta Thalassemia Major Patients Receiving Different Types of Iron Chelators in IranMeysam Seyedifar, Farid Abedin Dorkoosh, Amir Ali Hamidieh, et al.
Hemoglobin|June 14, 2019
A Homozygous Mutation on the HBA1 Gene Coding for Hb Charlieu (HBA1: c.320T>C) Together with β-Thalassemia Trait Results in Severe Hemolytic AnemiaThomas R L Klei, Sima Kheradmand Kia, Martijn Veldthuis, et al.
Mediterranean Journal of Hematology and Infectious Diseases|March 16, 2017
β-Thalassemia Distribution in the Old World: an Ancient Disease Seen from a Historical StandpointVincenzo De Sanctis, Christos Kattamis, Duran Canatan, et al.
Haematologica|January 29, 2008
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remissionFlora Peyvandi, Silvia Lavoretano, Roberta Palla, et al.
Thrombosis and Haemostasis|December 15, 2012
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluationGuglielmo Mariani, Mariasanta Napolitano, Alberto Dolce, et al.
Acta Bio-Medica : Atenei Parmensis|May 12, 2022
The The use of oral glucose-lowering agents (GLAs) in β-thalassemia patients with diabetes: Preliminary data from a retrospective study of ICET-A NetworkVincenzo De Sanctis, Ashraf Soliman, Ploutarchos Tzoulis, et al.
Journal of Thrombosis and Haemostasis : JTH|December 31, 2019
Fibrinogen concentrate for treatment of bleeding and surgical prophylaxis in congenital fibrinogen deficiency patientsToshko Lissitchkov, Bella Madan, Claudia Djambas Khayat, et al.
Pageof 32